Article
Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an…
BioMed Research International · 2022 · Kobra Tahermanesh, author Sahar Hakimpour, author Azam Govahi, author Fariborz Keyhanfar, author Abolfazl Mehdizadeh Kashi, author Shahla Chaichian, author Roya Shahriyaripour, author Marziyeh Ajdary, author Nauman Rahim Khan, Academic Editor
Key facts
| Title | Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor |
|---|---|
| First author | Kobra Tahermanesh, author Sahar Hakimpour, author Azam Govahi, author Fariborz Keyhanfar, author Abolfazl Mehdizadeh Kashi, author Shahla Chaichian, author Roya Shahriyaripour, author Marziyeh Ajdary, author Nauman Rahim Khan, Academic Editor |
| Journal | BioMed Research International |
| Published | Oct 10, 2022 |
| DOI | 10.1155/2022/1111777 |
| Devices mentioned | K181380 |
| Product codes mentioned | GIA, MAX |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1